Document Type
Article
Publication Date
8-27-2021
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced COVID-19 has emerged as a defining global health crisis in current times. Data from the World Health Organization shows demographic variations in COVID-19 severity and lethality. Diet may play a significant role in providing beneficial host cell factors contributing to immunity against deadly SARS-CoV-2 pathogenesis. Spices are essential components of the diet that possess anti-inflammatory, antioxidant, and antiviral properties. Hyperinflammation, an aberrant systemic inflammation associated with pneumonia, acute respiratory failure, and multiorgan dysfunction, is a major clinical outcome in COVID-19. Knowing the beneficial properties of spices, we hypothesize that spice-derived bioactive components can modulate host immune responses to provide protective immunity in COVID-19. This study emphasizes that biologically active components of spices might alleviate the sustained pro-inflammatory condition by inhibiting the activity of tumor necrosis factor-alpha (TNF-α), interleukins (IL6, IL8), and chemokine (CCL2) known to be elevated in COVID-19. Spices may potentially prevent the tissue damage induced by oxidative stress and pro-inflammatory mediators during SARS-CoV-2 infection. The current study also highlights the effects of spices on the antioxidant pathways mediated by Nrf2 (nuclear factor erythroid 2-related factor 2) and Hmox1 (heme oxygenase 1) to restore oxidative homeostasis and protect from aberrant tissue damage. Taken together, the anti-inflammatory and antioxidant activities of bioactive components of spices may hold a promise to target the cellular pathways for developing antivirals against SARS-CoV-2 and pan β-coronaviruses.
Recommended Citation
Sengupta, Sourodip; Bhattacharyya, Debina; Kasle, Grishma; Karmakar, Souvik; Sahu, Omkar; Ganguly, Anirban; Addya, Sankar; and Das Sarma, Jayasri, "Potential Immunomodulatory Properties of Biologically Active Components of Spices Against SARS-CoV-2 and Pan β-Coronaviruses" (2021). Kimmel Cancer Center Faculty Papers. Paper 80.
https://jdc.jefferson.edu/kimmelccfp/80
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
PubMed ID
34513735
Language
English
Comments
This article is the author’s final published version in Frontiers in Cellular and Infection Microbiology, Volume 11, August 2021, Article number 729622.
The published version is available at https://doi.org/10.3389/fcimb.2021.729622. Copyright © Sengupta et al.